Details for 2014702977

Up to date per 01.04.2026

Actions

Title / Product Name

RETARD-LORAZEPAMFORMULIERUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2014702977

EP Publication Number

2943185

E-Number

1334972

Language

PCT Number

US14010854

Publication Date

18.11.2015 A

18.11.2020 B1

Registration Date

18.11.2020

AT Publication Date

15.12.2020

Application Date

09.01.2014

Registration Number

Priorities

09.01.2013

201361750797 P

08.02.2013

201361762833 P

IPC

A61K 9/16 20060101AFI20200526BHEP

Maximum Duration of Protection

09.01.2034

Owner

Edgemont Pharmaceuticals, LLC Liquidating Trust1037 Raymond Blvd., Suite 1520 Newark, New Jersey 07102US

Representative

Patentanwaltskanzlei Matschnig & Forsthuber OGBiberstraße 221010 WienAT

Inventor

SALTEL, Douglas A.c/o Edgemont Pharmaceuticals 1250 Capital of Texas Hwy South Building 3 Suite 400 Austin, Texas 78746US

VACHON, Michaelc/o Edgemont Pharmaceuticals 1250 Capital of Texas Hwy South Building 3 Suite 400 Austin, Texas 78746US

Information about Fees